Association of Systemic Inflammation Response Index with Short-Term All-Cause Mortality in Decompensated Liver Cirrhosis Patients
Jin Cheng,Honglei Ju,Guixiang Wang,Chiyi He,Wei Wang
DOI: https://doi.org/10.2147/jir.s476743
IF: 4.5
2024-11-27
Journal of Inflammation Research
Abstract:Jin Cheng, 1, &ast Honglei Ju, 1, &ast Guixiang Wang, 2, &ast Chiyi He, 1 Wei Wang 1 1 Department of Gastroenterology, Yijishan Hospital of Wannan Medical College, Wuhu, People's Republic of China; 2 Department of Gastroenterology, The Second Affiliated Hospital of Wannan Medical College, Wuhu, People's Republic of China &astThese authors contributed equally to this work Correspondence: Wei Wang, Department of Gastroenterology, Yijishan Hospital of Wannan Medical College, No. 2, Zheshan West Road, Wuhu, Anhui Prov, 241000, People's Republic of China, Email Background: The Systemic Inflammation Response Index (SIRI) has demonstrated predictive capabilities for clinical outcomes in various diseases. However, its prognostic utility in decompensated liver cirrhosis (DLC) remains underexplored. This study aimed to investigate the association between SIRI and the risk of short-term (3 and 6 months) all-cause mortality in DLC patients. Methods: A total of 926 eligible patients with DLC from diverse etiologies was included in this study. In the initial cohort, the predictive accuracy of SIRI was evaluated using receiver operating characteristic (ROC) curve analysis. Patients were categorized into high- and low-SIRI groups based on the Youden index. Multivariable logistic regression analysis was employed to evaluate the independent association between SIRI and all-cause mortality. Restricted cubic spline (RCS) analysis was utilized to visualize the relationship between the continuous variable SIRI and mortality risk. These findings were validated in a validation cohort. Results: The initial cohort had mortality rates of 8.8% and 11.6% at 3 and 6 months, respectively. The SIRI level was significantly higher in the deceased group compared to the survival group. At both time points, SIRI was an independent indicator of all-cause mortality. RCS analysis demonstrated the risk of the risk of increased with an increase in SIRI value. The Validation cohort validated the independent association between higher SIRI levels and lower short-term all-cause mortality. Conclusion: This study's findings underscore the prognostic value of SIRI in DLC patients, indicating that higher SIRI levels are significantly associated with short-term adverse outcomes. Keywords: decompensated liver cirrhosis, systemic inflammation response index, prognosis, all-cause mortality Cirrhosis, a chronic liver condition, arises from persistent inflammation and fibrosis, marking the advanced stage of liver damage. 1,2 This disease stands as the 11th leading cause of global mortality and is notably the third most common cause of death among individuals between the ages of 45 and 64. 3,4 With an annual death toll of approximately 2 million, cirrhosis poses a significant health challenge worldwide. 3,4 Decompensated liver cirrhosis (DLC) signifies a pivotal and critical phase in the progression of liver cirrhosis. It is characterized by a decline in liver function and the emergence of severe, life-threatening complications. DLC is often associated with a grim prognosis and imposes a substantial burden on healthcare systems. 5,6 The short-term mortality rate among patients with DLC can soar to 15%. 7,8 underscoring the imperative need for early detection of high-risk individuals and the swift implementation of therapeutic interventions to ameliorate patient outcomes. Inflammation is a pivotal factor in the prognosis of liver cirrhosis. It can trigger a cascade of complications, such as ascites and hepatic encephalopathy, which in turn accelerate the progression of the disease. 9 Furthermore, inflammation contributes to the development of portal hypertension, a condition that can lead to devastating cirrhosis-related complications like variceal bleeding. 10 The onset of these complications is often a harbinger of poor short-term survival rates for patients. Systemic inflammation also heightens the risk of infections, which can intensify organ damage, playing a critical role in the outcomes of patients with DLC. 11 The Systemic Inflammation Response Index (SIRI) serves as a comprehensive indicator of inflammation, based on the counts of monocytes, neutrophils, and lymphocytes. 12 Recent research has revealed that SIRI is independently correlated with the prognosis of patients suffering from a variety of conditions, including different types of tumors, autoimmune rheumatic diseases, cardiovascular diseases, cerebral hemorrhage, and pneumonia. 12–19 However, the relationship between SIRI and the short-term prognosis in patients with decompensated cirrhosi -Abstract Truncated-
immunology